{"content":"<li class=\"n-box-item date-title\" data-end=\"1473307199\" data-start=\"1473220800\" data-txt=\"Sunday, December 22, 2019\">Wednesday, September  7, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3207517\" data-ts=\"1473288241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207517-fox-news-leads-cable-prime-time-ratings-again-fall-kicks-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fox News leads cable prime-time ratings again as fall kicks off</a></h4><ul>   <li>Fox News (<a href=\"https://seekingalpha.com/symbol/FOX\" title=\"Twenty-First Century Fox, Inc.\">FOX</a> <font color=\"red\">-0.6%</font>, <a href=\"https://seekingalpha.com/symbol/FOXA\" title=\"Twenty-First Century Fox, Inc.\">FOXA</a> <font color=\"red\">-0.2%</font>) sits again in a familiar spot, <a href=\"http://www.multichannel.com/news/content/fox-news-tops-primetime-ratings-charts/407565\" target=\"_blank\">atop the prime-time ratings</a> for cable networks.</li>    <li>The network -- despite being <a href=\"https://seekingalpha.com/news/3207248-nbc-hires-ailes-antagonist-sherman-settlements-fox-van-susteren\" target=\"_blank\">buffeted by the sexual harassment scandal</a> enveloping its former chief, Roger Ailes -- drew 2.1M viewers on average during the first week of the fall season, well outpacing HGTV (<a href=\"https://seekingalpha.com/symbol/SNI\" title=\"Scripps Networks Interactive, Inc.\">SNI</a> <font color=\"green\">+0.2%</font>) at No. 2, with 1.5M viewers.</li>    <li>ESPN (<a href=\"https://seekingalpha.com/symbol/DIS\" title=\"The Walt Disney Company\">DIS</a> <font color=\"red\">-0.1%</font>) and USA Network (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CMCSA\" title=\"Comcast Corporation\">CMCSA</a>) tied for third place with 1.4M viewers.</li>    <li>On a full-day basis (usually the stomping grounds of children's programming), Fox News also led, ahead of Nickelodeon (<a href=\"https://seekingalpha.com/symbol/VIA\" title=\"Viacom Inc.\">VIA</a> <font color=\"green\">+2.6%</font>, <a href=\"https://seekingalpha.com/symbol/VIAB\" title=\"Viacom Inc.\">VIAB</a> <font color=\"green\">+2.5%</font>) and Adult Swim (<a href=\"https://seekingalpha.com/symbol/TWX\" title=\"Time Warner Inc.\">TWX</a> <font color=\"green\">+0.4%</font>) among others.</li>    <li>In individual programming for the week, an episode of <i>Hannity</i> on Fox News topped the charts with 5.2M viewers, ahead of <i>Rizzoli and Isles</i> on TNT (NYSE:<a href=\"https://seekingalpha.com/symbol/TWX\" title=\"Time Warner Inc.\">TWX</a>) and Saturday college football on ESPN.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207517\" data-linked=\"Fox News leads cable prime-time ratings again as fall kicks off\" data-tweet=\"$FOX $FOX $FOXA - Fox News leads cable prime-time ratings again as fall kicks off https://seekingalpha.com/news/3207517-fox-news-leads-cable-prime-time-ratings-again-fall-kicks-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3207517-fox-news-leads-cable-prime-time-ratings-again-fall-kicks-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207515\" data-ts=\"1473287547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JUNO\" target=\"_blank\">JUNO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207515-juno-says-study-of-similar-cancer-treatment-showed-post-remission-t-cells\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juno says study of similar cancer treatment showed post-remission T cells</a></h4><ul>\n<li>Juno Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JUNO\" title=\"Juno Therapeutics\">JUNO</a>) <font color=\"green\">+7.9%</font> AH after <em>Science Translational Medicine</em> published a paper showing encouraging results for patients in a trial for a drug similar  to one Juno is developing for a blood cancer treatment.</li>\n<li>Juno says data for patients that received Cy/Flu lymphodepletion and the intermediate  dose of JCAR014 showed a promising early efficacy and side  effect profile.</li>\n<li>The study team for the paper included  scientists from Juno, which provided one of the trial's sources of  funding.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207515\" data-linked=\"Juno says study of similar cancer treatment showed post-remission T cells\" data-tweet=\"$JUNO - Juno says study of similar cancer treatment showed post-remission T cells https://seekingalpha.com/news/3207515-juno-says-study-of-similar-cancer-treatment-showed-post-remission-t-cells?source=tweet\" data-url=\"https://seekingalpha.com/news/3207515-juno-says-study-of-similar-cancer-treatment-showed-post-remission-t-cells\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207513\" data-ts=\"1473285574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSCO\" target=\"_blank\">TSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207513-tractor-supply-guides-q3-below-consensus-cuts-full-year-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tractor Supply guides Q3 below consensus, cuts full-year guidance</a></h4><ul>\n<li>Tractor Supply (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TSCO\" title=\"Tractor Supply Company\">TSCO</a>) <font color=\"red\">-9.4%</font> AH after guiding Q3 below consensus and lowering FY 2016 guidance, citing economic headwinds impacting consumer spending throughout many of its markets, particularly the energy producing and agricultural markets.</li>\n<li>TSCO now expects Q3 EPS of $0.65-$0.67 vs. $0.72 analyst consensus, on net sales forecast to increase 4.2%-5%  to $1.54B-$1.55B vs. $1.61B consensus and $1.48B in the year-ago quarter; comparable  store sales are seen flat to a 1% decline vs. a 2.9%  increase in last year's Q3.</li>\n<li>TSCO also cuts FY 2016 guidance, expecting EPS of $3.22-$3.26 vs. $3.38 analyst consensus and prior guidance of $3.35-$3.40, while revenues are forecast at $6.7B-$6.75B vs. $6.84B consensus and prior outlook of $6.8B-$6.9B.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207513\" data-linked=\"Tractor Supply guides Q3 below consensus, cuts full-year guidance\" data-tweet=\"$TSCO - Tractor Supply guides Q3 below consensus, cuts full-year guidance https://seekingalpha.com/news/3207513-tractor-supply-guides-q3-below-consensus-cuts-full-year-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3207513-tractor-supply-guides-q3-below-consensus-cuts-full-year-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207508\" data-ts=\"1473284184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207508-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a> <font color='green'>+5.8%</font>. <a href='https://seekingalpha.com/symbol/CLD' title='Cloud Peak Energy, Inc.'>CLD</a> <font color='green'>+3.7%</font>. <a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a> <font color='green'>+3.0%</font>. <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='green'>+2.9%</font>. <a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a> <font color='green'>+2.9%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a> <font color='red'>-10.4%</font>. <a href='https://seekingalpha.com/symbol/TSCO' title='Tractor Supply Company'>TSCO</a> <font color='red'>-9.1%</font>. <a href='https://seekingalpha.com/symbol/GWRE' title='Guidewire Software, Inc.'>GWRE</a> <font color='red'>-6.0%</font>. <a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a> <font color='red'>-5.7%</font>. <a href='https://seekingalpha.com/symbol/HTA' title='Healthcare Trust of America, Inc.'>HTA</a> <font color='red'>-3.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207508\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$JUNO $CLDPQ $CRC - After Hours Gainers / Losers https://seekingalpha.com/news/3207508-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3207508-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207502\" data-ts=\"1473282907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIR\" target=\"_blank\">PIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207502-pier-1minus-10-preliminary-results-miss-ceo-steps-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pier 1 -10% as preliminary results miss, CEO steps down</a></h4><ul>   <li>Pier 1 Imports (<a href=\"https://seekingalpha.com/symbol/PIR\" title=\"Pier 1 Imports Inc.\">PIR</a> <font color=\"green\">+3.5%</font>) is starting to sink after hours, <font color=\"red\">down 10.4%</font>, following word of a mutual agreement that CEO and President Alex Smith will step down from those roles and from his board seat, and after <a href=\"https://seekingalpha.com/news/3207500-pier-1-imports-reports-preliminary-fq2-results\" target=\"_blank\">preliminary Q2 results</a> that are disappointing compared to consensus.</li>    <li>The board says it's working with Korn Ferry to search for a new CEO in accordance with its succession planning.</li>    <li>The company has achieved a great deal of success in his 10 years of leadership, but \"Now it\u2019s time for me to do something new,\" Smith says in a statement.</li>    <li>Smith led a \"remarkable turnaround of the business from 2009 to 2013, creating one of the most profitable specialty stores in our sector,\" said Chairman Terry London. \"Subsequently, Alex spearheaded the transformation of Pier 1 Imports from a pure brick-and-mortar business to establish the competitive omni-channel platform we have in place today.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207502\" data-linked=\"Pier 1 -10% as preliminary results miss, CEO steps down\" data-tweet=\"$PIR - Pier 1 -10% as preliminary results miss, CEO steps down https://seekingalpha.com/news/3207502-pier-1minus-10-preliminary-results-miss-ceo-steps-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3207502-pier-1minus-10-preliminary-results-miss-ceo-steps-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207499\" data-ts=\"1473282518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LJPC\" target=\"_blank\">LJPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207499-european-regulator-oks-design-of-la-jolla-pharmas-pivotal-study-of-ljpcminus-401-in-beta\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European regulator OKs design of La Jolla Pharma&#39;s pivotal study of LJPC-401 in beta thalassemia, trial to start in mid-2017; shares up 4% after hours</a></h4><ul>\n<li>La Jolla Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LJPC\" title=\"La Jolla Pharmaceutical Co.\">LJPC</a>) perks up <font color=\"green\">4%</font> after hours, albeit on light volume, in response to its announcement that it has reached agreement with the European Medicines Agency on the design of a pivotal study assessing LJPC-401, a novel formulation of the iron regulator <a href=\"https://en.wikipedia.org/wiki/Hepcidin\" target=\"_blank\">hepcidin</a>, for the treatment of beta thalassemia (BT) patients suffering from iron overload. BT is an inherited disorder that reduces the production of hemoglobin.</li>\n<li>The primary endpoint of the study, expected to commence in mid-2017, will be a clinically relevant measurement directly related to iron overload.</li>\n<li>Management will host a conference call tomorrow morning at 9:00 am ET to discuss its plans.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207499\" data-linked=\"European regulator OKs design of La Jolla Pharma&#39;s pivotal study of LJPC-401 in beta thalassemia, trial to start in mid-2017; shares up 4% after hours\" data-tweet=\"$LJPC - European regulator OKs design of La Jolla Pharma&#39;s pivotal study of LJPC-401 in beta thalassemia, trial to start in mid-2017; shares up 4% after hours https://seekingalpha.com/news/3207499-european-regulator-oks-design-of-la-jolla-pharmas-pivotal-study-of-ljpcminus-401-in-beta?source=tweet\" data-url=\"https://seekingalpha.com/news/3207499-european-regulator-oks-design-of-la-jolla-pharmas-pivotal-study-of-ljpcminus-401-in-beta\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207497\" data-ts=\"1473281910\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVO\" target=\"_blank\">GEVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207497-gevo-to-launch-public-offering-size-not-disclosed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gevo to launch public offering; size not disclosed</a></h4><ul>\n<li>Gevo (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GEVO\" title=\"Gevo, Inc.\">GEVO</a>) <font color=\"red\">-20%</font> AH, giving up <a href=\"https://seekingalpha.com/news/3207453-gevo-inks-deal-lufthansa-supply-renewable-jet-fuel\" target=\"_blank\">gains</a> in today's regular trade, after announcing a proposed public offering of common stock and warrants; the size is not disclosed.</li>\n<li>Gevo says it plans to use the proceeds to fund working capital  and for other general corporate purposes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207497\" data-linked=\"Gevo to launch public offering; size not disclosed\" data-tweet=\"$GEVO - Gevo to launch public offering; size not disclosed https://seekingalpha.com/news/3207497-gevo-to-launch-public-offering-size-not-disclosed?source=tweet\" data-url=\"https://seekingalpha.com/news/3207497-gevo-to-launch-public-offering-size-not-disclosed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207481\" data-ts=\"1473281580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPE\" target=\"_blank\">HPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207481-hewlett-packard-enterpriseminus-3-8_8b-non-core-software-assets-sale-announced-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hewlett Packard Enterprise -3%; $8.8B non-core software assets sale announced with Q3 results</a></h4><ul>\n<li>HPE (NYSE:<a href=\"https://seekingalpha.com/symbol/HPE\" title=\"Hewlett Packard Enterprise\">HPE</a>) <a href=\"https://seekingalpha.com/news/3207474-hewlett-packard-enterprise-beats-0_04-misses-revenue\" target=\"_blank\">registered</a> Q3 revenue ($12.2B) 6.5% lower than the prior year period and missed the current period's consensus estimates by $440M. Most attention, however, is focused on an arrangement with Micro Focus.</li>\n<li>HPE shareholders will retain 50.1% ownership of a newly-formed company, while HPE will receive a cash payment of $2.5B.</li>\n<li>Assets unloaded include Application Delivery Management, Big Data, Enterprise Security, Information Management &amp; Governance and IT Operations Management businesses.</li>\n<li>HPE president and CEO Meg Whitman: \"Today's announced spin-merge of our non-core software assets with Micro Focus is another important step in our strategy to unlock a faster growing, higher margin, stronger cash flow company. As we said in the Enterprise Services announcement last quarter, both software and services remain key enablers of our go-forward strategy, and we are focused on building the right portfolio to win in our target markets. We believe the portfolio changes we've made over the past year are setting up HPE for long-term success while unlocking tremendous value for our shareholders.\"</li>\n<li>Regarding Q3 figures, revenues from Enterprise Group ($6.5B), Enterprise Services ($4.7B) and Sotware ($738M) declined 8%, 5% and 18% on Y/Y bases, respectively. Financial Services revenue increased 1% Y/Y to $812M.</li>\n<li>Projects Q4 EPS of $0.58-$0.63 and FY 2016 EPS of $1.90-$1.95.</li>\n<li><a href=\"https://www.hpe.com/us/en/newsroom/news-archive/featured-article/2016/09/CEO-Meg-Whitman-on-HPEs-Plans-to-Spin-Off-Merge-Non-Core-Software-Assets-With-Micro-Focus.html\" target=\"_blank\">Meg Whitman letter on Micro Focus deal</a></li>\n<li><a href=\"http://78449.choruscall.com/dataconf/productusers/hpe/mediaframe/16453/indexr.html\" target=\"_blank\">Conference call</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207481\" data-linked=\"Hewlett Packard Enterprise -3%; $8.8B non-core software assets sale announced with Q3 results\" data-tweet=\"$HPE - Hewlett Packard Enterprise -3%; $8.8B non-core software assets sale announced with Q3 results https://seekingalpha.com/news/3207481-hewlett-packard-enterpriseminus-3-8_8b-non-core-software-assets-sale-announced-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3207481-hewlett-packard-enterpriseminus-3-8_8b-non-core-software-assets-sale-announced-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207494\" data-ts=\"1473281240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPRX\" target=\"_blank\">RPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207494-repros-proellex-successful-in-mid-stage-endometriosis-study-shares-ahead-42-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Repros&#39; Proellex successful in mid-stage endometriosis study; shares ahead 42% after hours</a></h4><ul>\n<li>Thinly traded nano cap Repros Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a>) is up <font color=\"green\">42%</font> after hours on on increased volume in response to its announcement of positive results from a Phase 2 study assessing Proellex (telapristone acetate) for the treatment of premenopausal women with pelvic pain associated with endometriosis.</li>\n<li>The <a href=\"https://clinicaltrials.gov/ct2/show/NCT01728454?term=proellex&amp;cond=endometriosis&amp;phase=1&amp;rank=3\" target=\"_blank\">60-subject, double-blind, placebo-controlled study</a> randomized participants to receive either 6 or 12 mg of Proellex or placebo for 18 weeks followed by an Off Drug Interval. The primary endpoint was the change from baseline in pelvic pain as measured by a scale called Biberoglu and Behrman Symptom Score (BBSS) over the treatment period.</li>\n<li>70% of the patients treated with Proellex became amenorrheic, which was associated with a substantial reduction in pain and analgesic use. Responses were similar between the two doses of Proellex so the reported results are pooled.</li>\n<li>The median percent change from baseline in BBSS score related to menstrual pain was a reduction of 85.4% compared to -37.5% for placebo (p=0.0008). Reductions in non-menstrual pain were also observed but they were similar between the treatment groups.</li>\n<li>Patients receiving Proellex showed a 56% reduction in total analgesic pill count compared to baseline versus a 30% reduction for placebo (p=0.0521). For non-prescription meds, the reductions were 74% and 11%, respectively (p=0.0423). The drug was generally well-tolerated.</li>\n<li>\n<a href=\"http://www.reprosrx.com/proellex.php\" target=\"_blank\">Proellex</a> is a small molecule compound that selectively blocks the progesterone receptor.</li>\n<li>The company intends to advance Proellex to Phase 3 development.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207494\" data-linked=\"Repros&#39; Proellex successful in mid-stage endometriosis study; shares ahead 42% after hours\" data-tweet=\"$RPRX - Repros&#39; Proellex successful in mid-stage endometriosis study; shares ahead 42% after hours https://seekingalpha.com/news/3207494-repros-proellex-successful-in-mid-stage-endometriosis-study-shares-ahead-42-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3207494-repros-proellex-successful-in-mid-stage-endometriosis-study-shares-ahead-42-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207493\" data-ts=\"1473281203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207493-viacom-hires-morgan-stanley-liontree-in-capital-structure-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viacom hires Morgan Stanley, LionTree in capital structure review</a></h4><ul>   <li>Viacom (<a href=\"https://seekingalpha.com/symbol/VIA\" title=\"Viacom Inc.\">VIA</a> <font color=\"green\">+2.6%</font>, <a href=\"https://seekingalpha.com/symbol/VIAB\" title=\"Viacom Inc.\">VIAB</a> <font color=\"green\">+2.5%</font>) has hired Morgan Stanley (NYSE:<a href=\"https://seekingalpha.com/symbol/MS\" title=\"Morgan Stanley\">MS</a>) and LionTree in a <a href=\"http://www.reuters.com/article/us-viacom-capital-idUSKCN11D2KK\" target=\"_blank\">review of its capital structure</a>, Reuters reports.</li>    <li>That could be an early sign of big changes to come with the <a href=\"https://seekingalpha.com/news/3206498-thr-viacoms-dauman-present-case-board-paramount-sale\" target=\"_blank\">departure of Philippe Dauman</a> from the helm.</li>    <li>The work is reportedly a short-term assignment, a source told Reuters.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207493\" data-linked=\"Viacom hires Morgan Stanley, LionTree in capital structure review\" data-tweet=\"$VIA $VIA $VIAB - Viacom hires Morgan Stanley, LionTree in capital structure review https://seekingalpha.com/news/3207493-viacom-hires-morgan-stanley-liontree-in-capital-structure-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3207493-viacom-hires-morgan-stanley-liontree-in-capital-structure-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207467\" data-ts=\"1473278530\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BV-OLD\" target=\"_blank\">BV-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207467-bazaarvoice-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bazaarvoice beats by $0.04, beats on revenue</a></h4><ul>\n<li>Bazaarvoice (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BV-OLD\" title=\"Bazaarvoice\">BV-OLD</a>): FQ1 EPS of $0.00 <font color=\"green\">beats by $0.04</font>.</li>\n<li>Revenue of $50.1M (+2.5% Y/Y) <font color=\"green\">beats by $1.13M</font>.</li>\n<li>Shares <font color=\"green\">+1.1%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207467\" data-linked=\"Bazaarvoice beats by $0.04, beats on revenue\" data-tweet=\"$BV-OLD - Bazaarvoice beats by $0.04, beats on revenue https://seekingalpha.com/news/3207467-bazaarvoice-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3207467-bazaarvoice-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207472\" data-ts=\"1473278331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRCI\" target=\"_blank\">SRCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207472-synergy-resourcesplus-5-2017-outlook-forecasts-meaningful-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synergy Resources +5% as 2017 outlook forecasts meaningful growth</a></h4><ul>     <li>Synergy Resources (SYRG <font color=\"green\">+5.1%</font>) is sharply higher after issuing its preliminary FY 2017 production and capex guidance, which includes $260M-$300M of spending for drilling and completion and ~68% production growth to 17.5K-20K boe/day assuming a two-rig program.</li>     <li>SYRG plans to drill 102 and complete 95 gross wells, which should be done before year-end 2016 with completion continuing into 2017.</li>     <li>SYRG says drilling operations are progressing on schedule at its two Evans pads, where each rig is scheduled to drill 11 wells.</li>     <li>Wunderlich reiterates its Buy rating on the stock, believing SYRG is on track with a total focus on execution.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207472\" data-linked=\"Synergy Resources +5% as 2017 outlook forecasts meaningful growth\" data-tweet=\"$SRCI - Synergy Resources +5% as 2017 outlook forecasts meaningful growth https://seekingalpha.com/news/3207472-synergy-resourcesplus-5-2017-outlook-forecasts-meaningful-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3207472-synergy-resourcesplus-5-2017-outlook-forecasts-meaningful-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207459\" data-ts=\"1473276833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207459-intel-reportedly-close-to-deal-tpg-involving-security-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel reportedly close to deal with TPG involving security business</a></h4><ul><li>Reports the two parties were conducting talks <a href=\"https://seekingalpha.com/news/3206725-bloomberg-intel-tpg-conducted-talks-regarding-security-unit-sale\" target=\"_blank\">surfaced</a> last week.</li><li>New developments are now <a href=\"https://twitter.com/CNBCnow/status/773602629175742464\" target=\"_blank\">claimed</a> to have emerged with a debt inclusive $4.2B sale of Intel's (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='red'>-0.5%</font>) security division supposedly close to realization.</li></ul><div class=\"tiny-share-widget\" data-id=\"3207459\" data-linked=\"Intel reportedly close to deal with TPG involving security business\" data-tweet=\"$INTC - Intel reportedly close to deal with TPG involving security business https://seekingalpha.com/news/3207459-intel-reportedly-close-to-deal-tpg-involving-security-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3207459-intel-reportedly-close-to-deal-tpg-involving-security-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207458\" data-ts=\"1473276720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207458-gw-pharma-jumps-21-on-takeover-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GW Pharma jumps 21% on takeover chatter</a></h4><ul>\n<li>GW Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/GWPH\" title=\"GW Pharmaceuticals plc\">GWPH</a> <font color=\"green\">+20.6%</font>) is up on more than double normal volume amidst rumors that it is working with an investment bank after unnamed companies contacted it about a possible transaction.</li>\n<li>The company's lead product candidate is Phase 3-stage Epidiolex (cannabidiol) in development for the treatment of certain kinds of epilepsy, infantile spasms and tuberous sclerosis complex. A U.S. marketing application is on tap for H1 2017 for Lennox-Gastaut syndrome and Dravet syndrome, two forms of childhood epilepsy.</li>\n<li>Fellow cannabidiol developers Insys Therapeutics (<a href=\"https://seekingalpha.com/symbol/INSY\" title=\"Insys Therapeutics, Inc.\">INSY</a> <font color=\"green\">+4.8%</font>) and Zynerba Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ZYNE\" title=\"Zynerba Pharmaceuticals\">ZYNE</a> <font color=\"green\">+9%</font>) are also up. Insys' candidate is in development for the treatment of cocaine dependence. Zynerba's (ZYN002) is a topical gel formulation for the potential treatment of knee pain due to arthritis and Fragile X syndrome.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207458\" data-linked=\"GW Pharma jumps 21% on takeover chatter\" data-tweet=\"$GWPH $GWPH $INSYQ - GW Pharma jumps 21% on takeover chatter https://seekingalpha.com/news/3207458-gw-pharma-jumps-21-on-takeover-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3207458-gw-pharma-jumps-21-on-takeover-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207454\" data-ts=\"1473275403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOFI\" target=\"_blank\">BOFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207454-bofi-loses-bid-to-silence-whisteblower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofI loses bid to silence whisteblower</a></h4><ul>\n<li>A federal judge has denied BofI Holdings's (<a href=\"https://seekingalpha.com/symbol/BOFI\" title=\"BofI Holding, Inc.\">BOFI</a> <font color=\"red\">-1.8%</font>) request for a preliminary injunction to stop former auditor Charles Erhart from disseminating confidential information and require him to return files he allegedly took from the company.</li>\n<li>Erhart last year sued the company, charging he was fired after pointing out unlawful conduct to his superiors and the government. BofI subsequently countersued, claiming Erhart violated the law by publishing confidential information.</li>\n<li>Source: Bloomberg</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207454\" data-linked=\"BofI loses bid to silence whisteblower\" data-tweet=\"$BOFI - BofI loses bid to silence whisteblower https://seekingalpha.com/news/3207454-bofi-loses-bid-to-silence-whisteblower?source=tweet\" data-url=\"https://seekingalpha.com/news/3207454-bofi-loses-bid-to-silence-whisteblower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207451\" data-ts=\"1473274801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207451-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/AIRG\" title=\"Airgain\">AIRG</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/PCYG\" title=\"Park City Group, Inc.\">PCYG</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/AAOI\" title=\"Applied Optoelectronics, Inc.\">AAOI</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/MIND\" title=\"Mitcham Industries, Inc.\">MIND</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/WDC\" title=\"Western Digital Corporation\">WDC</a> <font color=\"green\">+12%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/TSRI\" title=\"TSR, Inc.\">TSRI</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/SHSP\" title=\"SharpSpring, Inc.\">SHSP</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/SIGM\" title=\"Sigma Designs, Inc.\">SIGM</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/AMD\" title=\"Advanced Micro Devices, Inc.\">AMD</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/OOMA\" title=\"Ooma\">OOMA</a> <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207451\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$AIRG $PCYG $AAOI - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3207451-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3207451-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207453\" data-ts=\"1473274681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVO\" target=\"_blank\">GEVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207453-gevo-inks-deal-lufthansa-for-supply-of-renewable-jet-fuel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gevo inks deal with Lufthansa for supply of renewable jet fuel</a></h4><ul>     <li>Gevo (<a href=\"https://seekingalpha.com/symbol/GEVO\" title=\"Gevo, Inc.\">GEVO</a> <font color=\"green\">+20.9%</font>) jumps 20% after announcing it has entered a heads of agreement with Deutsche Lufthansa to supply its alcohol-to-jet fuel from its first commercial hydrocarbons facility, to be built in Luverne, Minn.</li>\n<li>Gevo says Lufthansa would purchase up to 8M gal/year of its ATJ fuel,  or up to 40M gallons over the five-year life of the off-take  agreement.</li>\n<li>Gevo also says the agreement, if fulfilled, would establish a selling price that is expected to  allow for an appropriate level of return on the capital required to  build-out the Luverne facility.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3207453\" data-linked=\"Gevo inks deal with Lufthansa for supply of renewable jet fuel\" data-tweet=\"$GEVO - Gevo inks deal with Lufthansa for supply of renewable jet fuel https://seekingalpha.com/news/3207453-gevo-inks-deal-lufthansa-for-supply-of-renewable-jet-fuel?source=tweet\" data-url=\"https://seekingalpha.com/news/3207453-gevo-inks-deal-lufthansa-for-supply-of-renewable-jet-fuel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207441\" data-ts=\"1473271489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207441-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources Inc.'>CRK</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/NRP' title='Natural Resource Partners LP'>NRP</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SYNL' title='Synalloy Corporation'>SYNL</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> URRE <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NGD' title='New Gold Inc'>NGD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/AAU' title='Almaden Minerals Ltd'>AAU</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/THM' title='International Tower Hill Mines Ltd'>THM</a> <font color='red'>-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3207441\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$CRK $NRP $BCEI - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3207441-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3207441-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207522\" data-ts=\"1473270971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMI\" target=\"_blank\">CMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207522-cummins-gets-sell-rating-deutsche-bank-mid-cycle-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cummins gets Sell rating at Deutsche Bank with mid-cycle warning</a></h4><ul>     <li>Cummins (<a href=\"https://seekingalpha.com/symbol/CMI\" title=\"Cummins Inc.\">CMI</a> <font color=\"green\">+2.4%</font>) is higher even as Deutsche Bank initiates coverage with a <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/09/8430282/deutsche-bank-warns-of-a-mid-cycle-crisis-impacting-cumm\" target=\"_blank\">Sell rating</a> and a $111 price target, saying CMI's market share for NAFTA heavy-duty truck engines has contracted from the peak level by 16 percentage points to 29% with potential for further pressure over time.</li>     <li>The firm notes that Paccar is moving toward its internal engine penetration target of 85%, and that Daimler is entering the North American market for medium-duty truck engines, and its DD8 platform is the \u201cmost viable competition\" with CMI's ISB engine.</li>     <li>Deutsche Bank says the two moves combined translate to a $0.90 mid-cycle EPS downside for CMI, not yet reflected in consensus estimates, with downside to the company\u2019s shares due to an expected downward revision of EPS forecasts.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207522\" data-linked=\"Cummins gets Sell rating at Deutsche Bank with mid-cycle warning\" data-tweet=\"$CMI - Cummins gets Sell rating at Deutsche Bank with mid-cycle warning https://seekingalpha.com/news/3207522-cummins-gets-sell-rating-deutsche-bank-mid-cycle-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3207522-cummins-gets-sell-rating-deutsche-bank-mid-cycle-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207437\" data-ts=\"1473269035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTDOY\" target=\"_blank\">NTDOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207437-nintendo-jumps-17-news-of-super-mario-run-game-for-apple-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nintendo jumps 17% with news of &#39;Super Mario Run&#39; game for Apple (updated)</a></h4><ul>     <li>Nintendo (<a href=\"https://seekingalpha.com/symbol/NTDOY\" title=\"Nintendo Co., Ltd. ADR\">OTCPK:NTDOY</a>) is spiking in U.S. trading, to <font color=\"green\">+17%</font> on the day, as the live Apple event is bringing videogamers' favorite Italian plumber to iOS.</li>     <li>\n<i>Super Mario Run,</i> a new game developed by Nintendo for Apple, is coming later this year.</li>     <li>The game will be available at a set price. Mario creator and gaming icon Shigeru Miyamoto was on hand to promote the game, a simple run game which can be played with one hand.</li>     <li>Nintendo may do better with an Apple windfall for Mario than it does with Pokemon Go, since it owns all of Mario-related intellectual property.</li>   <li>\n<b>Updated 1:31 p.m.:</b> Nintendo ADRs are now <b><font color=\"green\">up 21%</font></b> as the Apple/Nintendo connection deepens with news that smash hit <i>Pokemon Go</i> is coming to the Apple Watch.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3207437\" data-linked=\"Nintendo jumps 17% with news of &#39;Super Mario Run&#39; game for Apple (updated)\" data-tweet=\"$NTDOY - Nintendo jumps 17% with news of &#39;Super Mario Run&#39; game for Apple (updated) https://seekingalpha.com/news/3207437-nintendo-jumps-17-news-of-super-mario-run-game-for-apple-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3207437-nintendo-jumps-17-news-of-super-mario-run-game-for-apple-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207428\" data-ts=\"1473267603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207428-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HOME' title='At Home Group'>HOME</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/GYRO' title='Gyrodyne, LLC'>GYRO</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3207428\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$HOME $GYRO $SIEB - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3207428-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3207428-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207424\" data-ts=\"1473267268\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADPT\" target=\"_blank\">ADPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207424-adeptus-chief-hall-to-retire-shares-slump-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adeptus chief Hall to retire; shares slump 17%</a></h4><ul>\n<li>Adeptus Health (<a href=\"https://seekingalpha.com/symbol/ADPT\" title=\"Adeptus Health\">ADPT</a> <font color=\"red\">-16.8%</font>) Chairman &amp; CEO Thomas Hall has informed the company that he intends to retire as soon as a successor is hired or mid-2017 at the latest. He will continue as Chairman through his current term which ends at the 2017 Annual Meeting of Stockholders.</li>\n<li>The search for a new CEO is underway.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207424\" data-linked=\"Adeptus chief Hall to retire; shares slump 17%\" data-tweet=\"$ADPT $ADPT-RETIRED - Adeptus chief Hall to retire; shares slump 17% https://seekingalpha.com/news/3207424-adeptus-chief-hall-to-retire-shares-slump-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3207424-adeptus-chief-hall-to-retire-shares-slump-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207422\" data-ts=\"1473266619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207422-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/CGNT\" title=\"Cogentix Medical, Inc.\">CGNT</a> <font color=\"green\">+43%</font>. <a href=\"https://seekingalpha.com/symbol/RTRX\" title=\"Retrophin, Inc.\">RTRX</a> <font color=\"green\">+34%</font>. <a href=\"https://seekingalpha.com/symbol/AGIO\" title=\"Agios Pharmaceuticals, Inc.\">AGIO</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/SGMS\" title=\"Scientific Games Corp\">SGMS</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/RETA\" title=\"Reata Pharmaceuticals\">RETA</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/EVOK\" title=\"Evoke Pharma, Inc.\">EVOK</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/CRK\" title=\"Comstock Resources Inc.\">CRK</a> <font color=\"green\">+16%</font>. NVLS <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/CVGW\" title=\"Calavo Growers, Inc.\">CVGW</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/AIRG\" title=\"Airgain\">AIRG</a> <font color=\"green\">+14%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/SHLO\" title=\"Shiloh Industries, Inc.\">SHLO</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/ADPT\" title=\"Adeptus Health\">ADPT</a> <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/HDS\" title=\"HD Supply\">HDS</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/CDTI\" title=\"Clean Diesel Technologies, Inc.\">OTC:CDTI</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/SFM\" title=\"Sprouts Farmers Market\">SFM</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/NL\" title=\"NL Industries Inc.\">NL</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/ELMD\" title=\"Electromed, Inc.\">ELMD</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/CATB\" title=\"Catabasis Pharmaceuticals\">CATB</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/WATT\" title=\"Energous Corp.\">WATT</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/CASY\" title=\"Casey's General Stores, Inc.\">CASY</a> <font color=\"red\">-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207422\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CGNT $RTRX $AGIO - Midday Gainers / Losers https://seekingalpha.com/news/3207422-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3207422-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207418\" data-ts=\"1473265678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASY\" target=\"_blank\">CASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207418-investors-punish-caseys-general-stores-after-q2-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors punish Casey&#39;s General Stores after Q2 miss</a></h4><ul>\n<li>Casey's General Stores (<a href=\"https://seekingalpha.com/symbol/CASY\" title=\"Casey's General Stores, Inc.\">CASY</a> <font color=\"red\">-10.4%</font>) trades lower after reporting Q2 results.</li>\n<li>The trend of falling fuel revenue despite higher volume continued, while soft cigarette sales may been an unexpected factor.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3207194-caseys-general-stores-misses-0_11-misses-revenue\" target=\"_blank\">Caseys General Stores misses by $0.11, misses on revenue</a> (Sept. 6)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207418\" data-linked=\"Investors punish Casey&#39;s General Stores after Q2 miss\" data-tweet=\"$CASY - Investors punish Casey&#39;s General Stores after Q2 miss https://seekingalpha.com/news/3207418-investors-punish-caseys-general-stores-after-q2-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3207418-investors-punish-caseys-general-stores-after-q2-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207413\" data-ts=\"1473264632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207413-consumer-goods-top-gainers-losers-of-12-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:10 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CVGW' title='Calavo Growers, Inc.'>CVGW</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/MBUU' title='Malibu Boats, Inc.'>MBUU</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/MCFT' title='MasterCraft Boat Holdings, Inc.'>MCFT</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3207413\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:10 pm\" data-tweet=\"$CVGW $MBUU $NVFY - Consumer Goods - Top Gainers / Losers as of 12:10 pm https://seekingalpha.com/news/3207413-consumer-goods-top-gainers-losers-of-12-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3207413-consumer-goods-top-gainers-losers-of-12-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207412\" data-ts=\"1473264193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DSX\" target=\"_blank\">DSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207412-select-transportation-stocks-churn-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select transportation stocks churn higher</a></h4><ul>\n<li>Transportation stocks are solidly higher across select parts of the broad sector.</li>\n<li>Some technical traders think the sector is on a breakout pattern, while analysts are honed in on conference presentations where Q3 updates are being spilled.</li>\n<li>Notable gainers include Diana Shipping (<a href=\"https://seekingalpha.com/symbol/DSX\" title=\"Diana Shipping, Inc.\">DSX</a> <font color=\"green\">+8.3%</font>), Scorpio Bulkers (<a href=\"https://seekingalpha.com/symbol/SALT\" title=\"Scorpio Bulkers Inc\">SALT</a> <font color=\"green\">+7.5%</font>), Safe Bulkers (<a href=\"https://seekingalpha.com/symbol/SB\" title=\"Safe Bulkers Inc.\">SB</a> <font color=\"green\">+4.8%</font>), and Panagaea Logistics Solutions (<a href=\"https://seekingalpha.com/symbol/PANL\" title=\"Pangaea Logistics Solutions Ltd.\">PANL</a> <font color=\"green\">+13.4%</font>), Celadon Group (<a href=\"https://seekingalpha.com/symbol/CGI\" title=\"Celadon Group, Inc.\">CGI</a> <font color=\"green\">+4.2%</font>), USA Truck (<a href=\"https://seekingalpha.com/symbol/USAK\" title=\"USA Truck, Inc.\">USAK</a> <font color=\"green\">+3.5%</font>), American Airlines Group (<a href=\"https://seekingalpha.com/symbol/AAL\" title=\"American Airlines Group\">AAL</a> <font color=\"green\">+6.2%</font>), United Continental (<a href=\"https://seekingalpha.com/symbol/UAL\" title=\"United Continental Holdings, Inc\">UAL</a> <font color=\"green\">+5.6%</font>), Delta Air Lines (<a href=\"https://seekingalpha.com/symbol/DAL\" title=\"Delta Air Lines, Inc.\">DAL</a> <font color=\"green\">+5.4%</font>), CSX Corp (<a href=\"https://seekingalpha.com/symbol/CSX\" title=\"CSX Corporation\">CSX</a> <font color=\"green\">+1.6%</font>), and Roadrunner Transportation Systems (<a href=\"https://seekingalpha.com/symbol/RRTS\" title=\"Roadrunner Transportation Systems, Inc.\">RRTS</a> <font color=\"green\">+2.1%</font>), and Swift Transportation (SWFT <font color=\"green\">+0.8%</font>).</li>\n<li>The Dow Jones Transportation Index is <font color=\"green\">up 1.11%</font> vs. slight declines for broad market averages.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207412\" data-linked=\"Select transportation stocks churn higher\" data-tweet=\"$DSX $DSX $SALT - Select transportation stocks churn higher https://seekingalpha.com/news/3207412-select-transportation-stocks-churn-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3207412-select-transportation-stocks-churn-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207398\" data-ts=\"1473262653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207398-advanced-micro-devices-hit-hard-remains-top-sector-performer-on-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advanced Micro Devices hit hard, remains top sector performer on the year</a></h4><ul>\n<li>Despite a jarring reaction to concurrent common stock and senior note offerings <a href=\"http://www.amd.com/en-us/press-releases/Pages/amd-announces-public-2016sep06.aspx\" target=\"_blank\">announced</a> yesterday, Advanced Micro Devices (<a href=\"https://seekingalpha.com/symbol/AMD\" title=\"Advanced Micro Devices, Inc.\">AMD</a> <font color=\"red\">-6%</font>) continues to <a href=\"https://seekingalpha.com/news/3204528-advanced-micro-devices-plus-330-percent-year-markedly-outpacing-major-semiconductor\" target=\"_blank\">outpace all major competitors</a> when it comes to share price growth over the last 12 months.</li>\n<li>At present levels, AMD is <font color=\"green\">up 267%</font> since this point last September while Nvidia (<a href=\"https://seekingalpha.com/symbol/NVDA\" title=\"NVIDIA Corporation\">NVDA</a> <font color=\"red\">-1.3%</font>), second in growth over the same period, is <font color=\"green\">up around 175%</font>.</li>\n<li>Though short-term prospects are realizing a negative impact on the developments, the company appears to be increasingly prioritizing a more long-term strategic focus.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207398\" data-linked=\"Advanced Micro Devices hit hard, remains top sector performer on the year\" data-tweet=\"$AMD $AMD $NVDA - Advanced Micro Devices hit hard, remains top sector performer on the year https://seekingalpha.com/news/3207398-advanced-micro-devices-hit-hard-remains-top-sector-performer-on-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3207398-advanced-micro-devices-hit-hard-remains-top-sector-performer-on-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207401\" data-ts=\"1473261933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GVP\" target=\"_blank\">GVP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207401-gse-awarded-two-projects-to-modernize-nuclear-simulators\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GSE awarded two projects to modernize nuclear simulators</a></h4><ul>     <li>GSE Systems (<a href=\"https://seekingalpha.com/symbol/GVP\" title=\"GSE Systems, Inc\">GVP</a> <font color=\"green\">+5.2%</font>) is higher after receiving contracts to update nuclear site simulator platforms for customers in the U.K. and Japan; the two projects add more than $6M to its backlog and include options that \"could grow backlog significantly further.\"</li>     <li>GSE says the technical engineering and software solutions will provide nuclear power plant operators with modern simulation technology to train operators and provide assistance with complex engineering problems that require solutions.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207401\" data-linked=\"GSE awarded two projects to modernize nuclear simulators\" data-tweet=\"$GVP - GSE awarded two projects to modernize nuclear simulators https://seekingalpha.com/news/3207401-gse-awarded-two-projects-to-modernize-nuclear-simulators?source=tweet\" data-url=\"https://seekingalpha.com/news/3207401-gse-awarded-two-projects-to-modernize-nuclear-simulators\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207367\" data-ts=\"1473260402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207367-healthcare-top-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top Gainers / Losers as of 11:00 am</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RTRX' title='Retrophin, Inc.'>RTRX</a> <font color='green'>+43%</font>. <a href='https://seekingalpha.com/symbol/CGNT' title='Cogentix Medical, Inc.'>CGNT</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/AGIO' title='Agios Pharmaceuticals, Inc.'>AGIO</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/EVOK' title='Evoke Pharma, Inc.'>EVOK</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a> <font color='green'>+16%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ADPT' title='Adeptus Health'>ADPT</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ELMD' title='Electromed, Inc.'>ELMD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CTLT' title='Catalent'>CTLT</a> <font color='red'>-7%</font>. STEM <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3207367\" data-linked=\"Healthcare - Top Gainers / Losers as of 11:00 am\" data-tweet=\"$RTRX $CGNT $AGIO - Healthcare - Top Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3207367-healthcare-top-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3207367-healthcare-top-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207392\" data-ts=\"1473259969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207392-bank-of-canada-on-hold-notes-drop-in-exports-loonie-slides\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank of Canada on hold, but notes drop in exports; loonie slides</a></h4><ul>\n<li>As expected, the Bank of Canada leaves its benchmark rate unchanged at 0.5%. In the <a href=\"http://www.bankofcanada.ca/2016/09/fad-press-release-2016-09-07/\" target=\"_blank\">accompanying statement</a>, though, the bank mentions a larger-than-expected drop in exports as hitting economic activity.</li>\n<li>Those words have shaved nearly 100 pips from the loonie (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/FXC\" title=\"CurrencyShares Canadian Dollar Trust ETF\">FXC</a>), now <font color=\"red\">lower by 0.5%</font> vs. the dollar at $0.7748. Canadian stocks are <font color=\"red\">down 0.15%</font>.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/EWC\" title=\"iShares MSCI Canada ETF\">EWC</a>, <a href=\"https://seekingalpha.com/symbol/CNDA\" title=\"IQ Canada Small Cap ETF\">CNDA</a>, <a href=\"https://seekingalpha.com/symbol/EWCS\" title=\"iShares MSCI Canada Small Cap Index ETF\">EWCS</a>, <a href=\"https://seekingalpha.com/symbol/FCAN\" title=\"First Trust Canada AlphaDex ETF\">FCAN</a>, <a href=\"https://seekingalpha.com/symbol/QCAN\" title=\"SPDR MSCI Canada Quality Mix ETF\">QCAN</a>, <a href=\"https://seekingalpha.com/symbol/HEWC\" title=\"iShares Currency Hedged MSCI Canada ETF\">HEWC</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207392\" data-linked=\"Bank of Canada on hold, but notes drop in exports; loonie slides\" data-tweet=\"$FXC $EWC $CNDA - Bank of Canada on hold, but notes drop in exports; loonie slides https://seekingalpha.com/news/3207392-bank-of-canada-on-hold-notes-drop-in-exports-loonie-slides?source=tweet\" data-url=\"https://seekingalpha.com/news/3207392-bank-of-canada-on-hold-notes-drop-in-exports-loonie-slides\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207390\" data-ts=\"1473259940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JW.A\" target=\"_blank\">JW.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207390-publisher-wileyminus-6_4-education-decline-paces-falling-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Publisher Wiley -6.4% as Education decline paces falling profit</a></h4><ul>   <li>John Wiley &amp; Sons (NYSE:<a href=\"https://seekingalpha.com/symbol/JW.A\" title=\"John Wiley &amp; Sons, Inc.\">JW.A</a>) has <font color=\"red\">slipped 6.4%</font> after <a href=\"https://seekingalpha.com/news/3207309-john-wiley-and-sons-misses-0_08-misses-revenue\" target=\"_blank\">fiscal Q1 earnings</a> that missed on top and bottom lines</li>    <li>Traditional book publishing \"remained under considerable market pressure, particularly in Education,\" said CEO Mark Allin, while the company saw positives in digital solutions growth and research journals.</li>    <li>Adjusted EPS fell 9% in constant currency, and revenues dropped 2% on the same basis.</li>    <li>Revenue by segment: Research, $234.4M (down 1%); Professional Development, $96.1M (down 3%); Education, $73.8M (down 15%).</li>    <li>The company reaffirmed its full-year outlook for adjusted EPS to decline in mid-single digits and for flat revenues -- excluding foreign exchange, impacts from the Atypon acquisition and a favorable impact from shifting to time-based journal subscriptions.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3207390\" data-linked=\"Publisher Wiley -6.4% as Education decline paces falling profit\" data-tweet=\"$JW.A - Publisher Wiley -6.4% as Education decline paces falling profit https://seekingalpha.com/news/3207390-publisher-wileyminus-6_4-education-decline-paces-falling-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3207390-publisher-wileyminus-6_4-education-decline-paces-falling-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207388\" data-ts=\"1473259474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBUU\" target=\"_blank\">MBUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207388-malibu-boats-rallies-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Malibu Boats rallies after earnings</a></h4><ul> <li>Malibu Boats (<a href=\"https://seekingalpha.com/symbol/MBUU\" title=\"Malibu Boats, Inc.\">MBUU</a> <font color=\"green\">+15%</font>) jumps after cruising past estimates with its Q2 report.</li> <li>Unit volume was up 2% to 922 boats during the quarter.</li> <li>Net sales per unit increased 7.7% to $72,321.</li> <li>The company says dealers and customers are providing positive reviews for the new 22 MXZ and 24 MXZ boat models.</li> <li>Shares of MBUU traced back over $16 for the first time since early May.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3207282-malibu-boats-beats-0_02-beats-revenue\" target=\"_blank\">Malibu Boats beats by $0.02, beats on revenue</a> (Sept. 7)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207388\" data-linked=\"Malibu Boats rallies after earnings\" data-tweet=\"$MBUU - Malibu Boats rallies after earnings https://seekingalpha.com/news/3207388-malibu-boats-rallies-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3207388-malibu-boats-rallies-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207375\" data-ts=\"1473258408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGNT\" target=\"_blank\">CGNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207375-cogentix-nabs-25m-equity-investment-priced-premium-shares-ahead-41\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cogentix nabs $25M equity investment priced at a premium; shares ahead 41%</a></h4><ul>\n<li>Thinly traded nano cap Cogentix Medical (<a href=\"https://seekingalpha.com/symbol/CGNT\" title=\"Cogentix Medical, Inc.\">CGNT</a> <font color=\"green\">+40.8%</font>) heads north on a 12x surge in volume, albeit on turnover of only 627K shares, in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/894237/000114036116079027/form8k.htm\" target=\"_blank\">announcement </a>of a $25M equity investment by institutional shop Accelmed Growth Partners. L.P. Under the terms of the Purchase Agreement, Accelmed has agreed to buy 16,129,033 common shares at $1.55, almost a 30% premium to yesterday's close of $1.20.</li>\n<li>As a condition of the deal, the company will convert the principal and accrued interest in promissory notes held by Director Lewis Pell into shares of common stock at $1.67, representing a total value of $29.5M.</li>\n<li>Mr. Pell and Accelmed will control the majority of the company's shares. Cogentix has also agreed to amend its bylaws to reduce the required quorum for all stockholders meetings to 1/3 of all issued and outstanding shares of voting stock. Accelmed will nominate a candidate to serve as Chairman.</li>\n<li>\n<a href=\"http://www.cogentixmedical.com/\" target=\"_blank\">Cogentix </a>develops and markets a line fiber optic and video endoscopy products under its <a href=\"http://www.cogentixmedical.com/health-care-professionals/products/primesight\" target=\"_blank\">PrimeSight </a>brand.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207375\" data-linked=\"Cogentix nabs $25M equity investment priced at a premium; shares ahead 41%\" data-tweet=\"$CGNT - Cogentix nabs $25M equity investment priced at a premium; shares ahead 41% https://seekingalpha.com/news/3207375-cogentix-nabs-25m-equity-investment-priced-premium-shares-ahead-41?source=tweet\" data-url=\"https://seekingalpha.com/news/3207375-cogentix-nabs-25m-equity-investment-priced-premium-shares-ahead-41\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207384\" data-ts=\"1473258388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIGM\" target=\"_blank\">SIGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207384-sigma-designs-post-earnings-gain-short-lived-sharesminus-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sigma Designs&#39; post-earnings gain short-lived; shares -7%</a></h4><ul>\n<li>Sigma Designs (<a href=\"https://seekingalpha.com/symbol/SIGM\" title=\"Sigma Designs, Inc.\">SIGM</a> <font color=\"red\">-6.6%</font>) reported better-than-expected <a href=\"https://seekingalpha.com/news/3207191-sigma-designs-beats-0_06-beats-revenue\" target=\"_blank\">Q2 results</a> following yesterday's close, though an initial <a href=\"https://seekingalpha.com/news/3207210-sigma-designs-plus-7-percent-hours-strong-q2-earnings\" target=\"_blank\">positive reaction</a> has now turned to sharp selling on outlook concerns.</li>\n<li>The company projected Q3 total revenue of $62M-$65M, gross margins of 47%-50% and operating expenses under $28M on its <a href=\"https://seekingalpha.com/article/4004499-sigma-designs-sigm-ceo-thinh-tran-q2-2017-results-earnings-call-transcript?part=single\" target=\"_blank\">earnings call</a> and further expects to again be profitable on a non-GAAP basis in the coming quarter.</li>\n<li>Needham &amp; Company has nonetheless subsequently <a href=\"http://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Reiterates+Buy+on+Sigma+Designs+%28SIGM%29+Following+Solid+2Q+Report/12007211.html\" target=\"_blank\">restated</a> a Buy rating and $13 price target (current price $7.78) despite the light forecast.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207384\" data-linked=\"Sigma Designs&#39; post-earnings gain short-lived; shares -7%\" data-tweet=\"$SIGM - Sigma Designs&#39; post-earnings gain short-lived; shares -7% https://seekingalpha.com/news/3207384-sigma-designs-post-earnings-gain-short-lived-sharesminus-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3207384-sigma-designs-post-earnings-gain-short-lived-sharesminus-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207383\" data-ts=\"1473258331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDPI\" target=\"_blank\">SDPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207383-superior-drilling-products-to-launch-5m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Superior Drilling Products to launch 5M-share offering</a></h4><ul>     <li>Superior Drilling Products (<a href=\"https://seekingalpha.com/symbol/SDPI\" title=\"Superior Drilling Products, Inc.\">SDPI</a> <font color=\"red\">-3%</font>) announces a 5M-share public offering, with an underwriters option to purchase up to an additional 750K common shares.</li>     <li>SDPI says it plans to use the proceeds to pay down debt, including amounts outstanding under its FNCC credit  facility, its recently completed bridge financing, its Hard Rock Note, and for general corporate purposes, including working capital.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207383\" data-linked=\"Superior Drilling Products to launch 5M-share offering\" data-tweet=\"$SDPI - Superior Drilling Products to launch 5M-share offering https://seekingalpha.com/news/3207383-superior-drilling-products-to-launch-5m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3207383-superior-drilling-products-to-launch-5m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207382\" data-ts=\"1473258148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFM\" target=\"_blank\">SFM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207382-grocery-store-stocks-in-retreat-on-deflation-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grocery store stocks in retreat on deflation concerns</a></h4><ul> <li>Weak guidance issued earlier today from Sprouts Farmers Market (<a href=\"https://seekingalpha.com/symbol/SFM\" title=\"Sprouts Farmers Market\">SFM</a> <font color=\"red\">-13.9%</font>) is slicing deeply through the grocery store sector.</li> <li>If there's a word to sum up the negative vibe in the sector it would be \"deflation\" after Sprouts execs came clean on the negative impact of falling prices.</li> <li>Decliners include Whole Foods Market (WFM <font color=\"red\">-5.2%</font>), Kroger (<a href=\"https://seekingalpha.com/symbol/KR\" title=\"Kroger Co.\">KR</a> <font color=\"red\">-4.1%</font>), Supervalu (<a href=\"https://seekingalpha.com/symbol/SVU\" title=\"SUPERVALU Inc.\">SVU</a> <font color=\"red\">-2%</font>), Ingles Markets (<a href=\"https://seekingalpha.com/symbol/IMKTA\" title=\"Ingles Markets, Incorporated\">IMKTA</a> <font color=\"red\">-3.4%</font>), and Natural Grocers by Vitamin Cottage (<a href=\"https://seekingalpha.com/symbol/NGVC\" title=\"Natural Grocers\">NGVC</a> <font color=\"red\">-3.2%</font>).</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3207292-sprouts-farmers-market-slumps-updating-guidance\" target=\"_blank\">Sprouts Farmers Market slumps after updating guidance</a> (Sept. 7)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3207382\" data-linked=\"Grocery store stocks in retreat on deflation concerns\" data-tweet=\"$SFM $SFM $AMZN - Grocery store stocks in retreat on deflation concerns https://seekingalpha.com/news/3207382-grocery-store-stocks-in-retreat-on-deflation-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3207382-grocery-store-stocks-in-retreat-on-deflation-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207378\" data-ts=\"1473257891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207378-elephant-talkplus-7_3-after-strategic-deal-expeto\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elephant Talk +7.3% after strategic deal with Expeto</a></h4><ul>   <li>Elephant Talk Communications (ETAK) is <font color=\"green\">up 7.3%</font> after signing a strategic deal with Expeto to expand into enterprise and \"Internet of Things\" markets.</li>    <li>The companies will collaborate on bringing Elephant Talk's cloud-based mobility services to the new markets.</li>    <li>Expeto works on controlling and managing core LTE networks. The partnership is designed to respond to a growing market demand from enterprises to utilize MVNO (mobile virtual network operator) services themselves.</li>    <li>Gartner says that by 2018, the top 1,000 global enterprises will be implementing MVNO capabilities on some scale to support IoT, the companies note.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207378\" data-linked=\"Elephant Talk +7.3% after strategic deal with Expeto\" data-tweet=\"$TEUM - Elephant Talk +7.3% after strategic deal with Expeto https://seekingalpha.com/news/3207378-elephant-talkplus-7_3-after-strategic-deal-expeto?source=tweet\" data-url=\"https://seekingalpha.com/news/3207378-elephant-talkplus-7_3-after-strategic-deal-expeto\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207366\" data-ts=\"1473256461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSIC-OLD\" target=\"_blank\">FSIC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207366-fs-investment-lower-barclays-heads-to-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FS Investment lower as Barclays heads to the sidelines</a></h4><ul><li>The run since the lows early this year has brought FS Investment (NYSE:<a href='https://seekingalpha.com/symbol/FSIC-OLD' title='FS Investment Corporation'>FSIC-OLD</a>)&nbsp;<font color='green'>higher by about 25%</font>. Barclays downgrades to Equal Weight from Overweight.</li><li>Shares are&nbsp;<font color='red'>down 1.2%</font>&nbsp;in early action today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3207366\" data-linked=\"FS Investment lower as Barclays heads to the sidelines\" data-tweet=\"$FSIC-OLD - FS Investment lower as Barclays heads to the sidelines https://seekingalpha.com/news/3207366-fs-investment-lower-barclays-heads-to-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3207366-fs-investment-lower-barclays-heads-to-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207361\" data-ts=\"1473255792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEYE\" target=\"_blank\">FEYE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207361-fireeye-founder-ashar-aziz-resigns-from-board-of-directors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FireEye founder Ashar Aziz resigns from board of directors</a></h4><ul><li>An&nbsp;<a href=\"https://seekingalpha.com/filing/3217425\" target=\"_blank\">8-K filing</a> notes the decision \"was not the result of any disagreement.\"</li><li>Aziz founded FireEye (<a href='https://seekingalpha.com/symbol/FEYE' title='FireEye, Inc.'>FEYE</a> <font color='green'>+3.2%</font>) in 2004 and had served as a director since.</li><li>The resignation is effective immediately.</li></ul><div class=\"tiny-share-widget\" data-id=\"3207361\" data-linked=\"FireEye founder Ashar Aziz resigns from board of directors\" data-tweet=\"$FEYE - FireEye founder Ashar Aziz resigns from board of directors https://seekingalpha.com/news/3207361-fireeye-founder-ashar-aziz-resigns-from-board-of-directors?source=tweet\" data-url=\"https://seekingalpha.com/news/3207361-fireeye-founder-ashar-aziz-resigns-from-board-of-directors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207360\" data-ts=\"1473255569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVOK\" target=\"_blank\">EVOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207360-evoke-up-19-on-progress-to-clarify-nda-requirements-for-lead-product-candidate-evkminus-001\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evoke up 19% on progress to clarify NDA requirements for lead product candidate EVK-001</a></h4><ul>\n<li>Evoke Pharma (<a href=\"https://seekingalpha.com/symbol/EVOK\" title=\"Evoke Pharma, Inc.\">EVOK</a> <font color=\"green\">+18.7%</font>) perks up after the company disclosed the results from its pre-NDA meeting with the FDA regarding lead product candidate Gimoti (EVK-001)(metoclopramide nasal spray) for the relief of symptoms related to acute/recurrent diabetic gastroparesis in adult women.</li>\n<li>The intent of the meeting was to clarify the content of the regulatory, CMC (chemistry, manufacturing and control) and non-clinical sections of the planned filing. Evoke submitted an information package describing the proposed content and format of the sections beforehand.</li>\n<li>Based on the agency's response to the information package and what was discussed during the meeting, the company believes it has the information it needs to complete the sections in a manner acceptable to the FDA.</li>\n<li>Evoke intends to request an additional meeting with the regulator to discuss the clinical data. In July, shares plummeted on the news that a Phase 3 study failed to achieve its primary endpoint.</li>\n<li>Read now <a href=\"https://seekingalpha.com/article/3993882-evoke-pharma-hop-ride-elevator-higher\" target=\"_blank\">Evoke Pharma: Hop On And Ride The Elevator Higher</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207360\" data-linked=\"Evoke up 19% on progress to clarify NDA requirements for lead product candidate EVK-001\" data-tweet=\"$EVOK - Evoke up 19% on progress to clarify NDA requirements for lead product candidate EVK-001 https://seekingalpha.com/news/3207360-evoke-up-19-on-progress-to-clarify-nda-requirements-for-lead-product-candidate-evkminus-001?source=tweet\" data-url=\"https://seekingalpha.com/news/3207360-evoke-up-19-on-progress-to-clarify-nda-requirements-for-lead-product-candidate-evkminus-001\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207355\" data-ts=\"1473254482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRAN\" target=\"_blank\">FRAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207355-francescas-pops-after-earnings-who-called\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Francesca&#39;s pops after earnings, here&#39;s who called it</a></h4><ul> <li>Francesca's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FRAN\" title=\"Francesca's Holdings Corp.\">FRAN</a>) pops in early trading after a Q2 performance which came in ahead of some beaten-down expectations.</li> <li>The retailer reported a flat comp even with e-commerce sales up 37% Y/Y, while a shift in sales mix led to a 30 bps drop in merchandise margin.</li> <li>\"As we enter the third quarter, we are pleased with initial results as we successfully executed our targeted back-to-school programs.\"</li> <li>The company raises Q3 EPS guidance to a range of $0.96 to $1.03.</li> <li>FRAN <font color=\"green\">+13.01%</font> premarket to $15.81. That makes SA contributor Josh Arnold's <a href=\"https://seekingalpha.com/article/3983275-francescas-margins-make-buy\" target=\"_blank\">bullish call</a> on Francesca's in June a +40% winner.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3207294-francescas-beats-0_09-beats-revenue\" target=\"_blank\">Francesca's beats by $0.09, beats on revenue</a> (Sept. 7)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207355\" data-linked=\"Francesca&#39;s pops after earnings, here&#39;s who called it\" data-tweet=\"$FRAN - Francesca&#39;s pops after earnings, here&#39;s who called it https://seekingalpha.com/news/3207355-francescas-pops-after-earnings-who-called?source=tweet\" data-url=\"https://seekingalpha.com/news/3207355-francescas-pops-after-earnings-who-called\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207354\" data-ts=\"1473254406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAOI\" target=\"_blank\">AAOI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207354-applied-optoelectronicsplus-22-pre-market-following-q3-guidance-increase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied Optoelectronics +22% pre-market following Q3 guidance increase</a></h4><ul>\n<li>Applied Optoelectronics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AAOI\" title=\"Applied Optoelectronics, Inc.\">AAOI</a>) raised its <a href=\"https://seekingalpha.com/news/3207204-applied-optoelectronics-ups-guidance-shares-plus-12-percent\" target=\"_blank\">revenue and EPS outlook</a> after yesterday's market close on what president and CEO Dr. Thompson Lin attributes to accelerated datacenter product demand.</li>\n<li>The company further adjusts its net income projection to $4.7M-$5.2M, above prior outlook of $2.9M-$3.8M, and maintains a gross margin projection of 30.5%-32%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207354\" data-linked=\"Applied Optoelectronics +22% pre-market following Q3 guidance increase\" data-tweet=\"$AAOI - Applied Optoelectronics +22% pre-market following Q3 guidance increase https://seekingalpha.com/news/3207354-applied-optoelectronicsplus-22-pre-market-following-q3-guidance-increase?source=tweet\" data-url=\"https://seekingalpha.com/news/3207354-applied-optoelectronicsplus-22-pre-market-following-q3-guidance-increase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207353\" data-ts=\"1473254323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONVO\" target=\"_blank\">ONVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207353-organovo-launches-second-3d-printed-tissue-service-shares-up-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Organovo launches second 3D printed tissue service; shares up 7% premarket</a></h4><ul>\n<li>Micro cap Organovo (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ONVO\" title=\"Organovo Holdings, Inc.\">ONVO</a>) is up <font color=\"green\">7%</font> premarket on increased volume in response to its announcement that it has commenced commercial contracting for its second 3D bioprinted tissue service, the ExVive Human Kidney.</li>\n<li>The company's first service, the ExVive Human Liver, was launched in 2015.</li>\n<li>The company expects to generate total revenues of $4M - 6M in fiscal 2017. In fiscal Q1 (calendar Q2) it booked $674K in product/service revenue, up over three-fold from a year earlier.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207353\" data-linked=\"Organovo launches second 3D printed tissue service; shares up 7% premarket\" data-tweet=\"$ONVO - Organovo launches second 3D printed tissue service; shares up 7% premarket https://seekingalpha.com/news/3207353-organovo-launches-second-3d-printed-tissue-service-shares-up-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3207353-organovo-launches-second-3d-printed-tissue-service-shares-up-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207351\" data-ts=\"1473254226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207351-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/RTRX\" title=\"Retrophin, Inc.\">RTRX</a> <font color=\"green\">+26%</font>. <a href=\"https://seekingalpha.com/symbol/AGIO\" title=\"Agios Pharmaceuticals, Inc.\">AGIO</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/FRAN\" title=\"Francesca's Holdings Corp.\">FRAN</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/EVOK\" title=\"Evoke Pharma, Inc.\">EVOK</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/APA\" title=\"Apache Corporation\">APA</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/ONVO\" title=\"Organovo Holdings, Inc.\">ONVO</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/CLCD\" title=\"CoLucid Pharmaceuticals\">CLCD</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/ARLZ-OLD\" title=\"Aralez Pharmaceuticals Inc.\">ARLZ-OLD</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/WDC\" title=\"Western Digital Corporation\">WDC</a> <font color=\"green\">+6%</font>.</li> <li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/SFM\" title=\"Sprouts Farmers Market\">SFM</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/HDS\" title=\"HD Supply\">HDS</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/CASY\" title=\"Casey's General Stores, Inc.\">CASY</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/SMLP\" title=\"Summit Midstream Partners\">SMLP</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/CTLT\" title=\"Catalent\">CTLT</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/PLAY\" title=\"Dave &amp; Buster's Entertainment, Inc.\">PLAY</a> <font color=\"red\">-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3207351\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$RTRX $AGIO $FRAN - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3207351-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3207351-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207348\" data-ts=\"1473253770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVGW\" target=\"_blank\">CVGW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207348-calavo-growers-beats-0_14-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Calavo Growers beats by $0.14, beats on revenue</a></h4><ul>\n<li>Calavo Growers (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CVGW\" title=\"Calavo Growers, Inc.\">CVGW</a>): FQ3 EPS of $0.73 <font color=\"green\">beats by $0.14</font>.</li>\n<li>Revenue of $263.2M (+13.2% Y/Y) <font color=\"green\">beats by $19.38M</font>.</li>\n<li>Shares <font color=\"green\">+1.3%</font> PM.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207348\" data-linked=\"Calavo Growers beats by $0.14, beats on revenue\" data-tweet=\"$CVGW - Calavo Growers beats by $0.14, beats on revenue https://seekingalpha.com/news/3207348-calavo-growers-beats-0_14-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3207348-calavo-growers-beats-0_14-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207341\" data-ts=\"1473253355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGIO\" target=\"_blank\">AGIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207341-agios-pharma-up-15-premarket-on-news-collaboration-partner-celgene-to-file-nda-for-agminus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agios Pharma up 15% premarket on news that collaboration partner Celgene to file NDA for AG-221 in AML by year end</a></h4><ul>\n<li>Agios Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AGIO\" title=\"Agios Pharmaceuticals, Inc.\">AGIO</a>) is up <font color=\"green\">15%</font> premarket on increased volume in response to the <a href=\"https://www.sec.gov/Archives/edgar/data/1439222/000119312516702691/d243119d8k.htm\" target=\"_blank\">announcement </a>that collaboration partner Celgene (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CELG\" title=\"Celgene Corporation\">CELG</a>) plans to file a New Drug Application (NDA) with the FDA by year end seeking approval of Agios' AG-221 for the treatment of patients with advanced blood cancers who have a mutation in a protein called isocitrate dehydrogenase-2 (IDH2). Celgene will be discussing its plans for the NDA today at the Citi 11th Annual Biotech Conference in Boston.</li>\n<li>The data supporting the NDA was generated in a Phase 1/2 study in patients with IDH2 mutation-positive acute myeloid leukemia (AML). AG-221 (enasidenib) inhibits IDH2.</li>\n<li>In May, Agios and Celgene announced a collaboration to discover, develop and commercialize novel immuno-oncology therapies based on Agios' cellular metabolism research platform. The new partnership followed the expiration of the discovery phase of their 2010 agreement, which includes AG-221.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3184019-celgene-agios-pharma-team-immuno-oncology-agios-4-percent-hours\" target=\"_blank\">Celgene and Agios Pharma team up in immuno-oncology; Agios up 4% after hours</a> (May 17)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207341\" data-linked=\"Agios Pharma up 15% premarket on news that collaboration partner Celgene to file NDA for AG-221 in AML by year end\" data-tweet=\"$AGIO $AGIO $CELG - Agios Pharma up 15% premarket on news that collaboration partner Celgene to file NDA for AG-221 in AML by year end https://seekingalpha.com/news/3207341-agios-pharma-up-15-premarket-on-news-collaboration-partner-celgene-to-file-nda-for-agminus?source=tweet\" data-url=\"https://seekingalpha.com/news/3207341-agios-pharma-up-15-premarket-on-news-collaboration-partner-celgene-to-file-nda-for-agminus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207334\" data-ts=\"1473252500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APA\" target=\"_blank\">APA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207334-apache-says-texas-discovery-potentially-holds-billions-of-barrels-of-oil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apache says Texas discovery potentially holds billions of barrels of oil</a></h4><ul>     <li>Apache (NYSE:<a href=\"https://seekingalpha.com/symbol/APA\" title=\"Apache Corporation\">APA</a>) <font color=\"green\">+9.1%</font> premarket after announcing it found a \"significant new resource play\" in  the Delaware Basin that could become one of the biggest energy finds of the past decade.</li>     <li>The Alpine High discovery is in an area near west Texas' Davis Mountains that had been overlooked by geologists and engineers, who believed it would be a poor fit for hydraulic fracturing; instead, the find <a href=\"http://www.wsj.com/articles/apache-has-high-hopes-for-new-oil-field-discovery-in-texas-1473245702\" target=\"_blank\">could be worth $8B</a> by conservative estimates, or even 10x more.</li>     <li>APA estimates hydrocarbons in place on its acreage position are 75T cf of gas and 3B barrels of oil in the Barnett and Woodford formations alone, with significant oil potential also in the shallower  Pennsylvanian, Bone Springs and Wolfcamp formations.</li>     <li>APA says it expects to direct 25% of its capex budget this year toward the field, but will require several years to ramp up production because of the need for pipelines and processing equipment; it has so far drilled 19 wells in the area.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207334\" data-linked=\"Apache says Texas discovery potentially holds billions of barrels of oil\" data-tweet=\"$APA - Apache says Texas discovery potentially holds billions of barrels of oil https://seekingalpha.com/news/3207334-apache-says-texas-discovery-potentially-holds-billions-of-barrels-of-oil?source=tweet\" data-url=\"https://seekingalpha.com/news/3207334-apache-says-texas-discovery-potentially-holds-billions-of-barrels-of-oil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207328\" data-ts=\"1473251487\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207328-delta-air-lines-updates-2h-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta Air Lines updates 2H forecast</a></h4><ul> <li>Delta Air Lines (NYSE:<a href=\"https://seekingalpha.com/symbol/DAL\" title=\"Delta Air Lines, Inc.\">DAL</a>) issues a guidance update ahead of a conference presentation.</li> <li>The company says it's on track for operating margin of 18% to 19% in Q3. A 7% decline in passenger unit revenue is forecast. System capacity is seen increasing around 1.5%.</li> <li>On the crucial issue of capacity growth, Delta tips off tightening in Asia and a moderate 2.5% rise in domestic ASMs.</li> <li>Delta has no hedge book in place for the rest of 2016, meaning it's paying market prices. The Delta refinery is tilting toward a mild loss for the year with crack spreads clipping profit.</li> <li>Delta says it's on a pace to deliver $1.5B in operating cash flow.</li> <li><a href=\"https://seekingalpha.com/filing/3217474\" target=\"_blank\">SEC Form 8-K</a></li> <li>DAL <font color=\"red\">-0.84%</font> premarket to $36.51.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207328\" data-linked=\"Delta Air Lines updates 2H forecast\" data-tweet=\"$DAL - Delta Air Lines updates 2H forecast https://seekingalpha.com/news/3207328-delta-air-lines-updates-2h-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3207328-delta-air-lines-updates-2h-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>88&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207324\" data-ts=\"1473250935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RTRX\" target=\"_blank\">RTRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207324-retrophins-sparsentan-successful-in-mid-stage-study-in-rare-kidney-disorder-shares-ahead-29\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retrophin&#39;s sparsentan successful in mid-stage study in rare kidney disorder; shares ahead 29% premarket</a></h4><ul>\n<li>Micro cap Retrophin (NASDAQ:<a href=\"https://seekingalpha.com/symbol/RTRX\" title=\"Retrophin, Inc.\">RTRX</a>) is up <font color=\"green\">29%</font> premarket on robust volume in response to its announcement of positive results in a Phase 2 clinical trial, DUET, evaluating sparsentan (RE-021) for the treatment of <a href=\"https://www.kidney.org/atoz/content/focal\" target=\"_blank\">focal segmental glomerulosclerosis</a>, a rare kidney disorder that leads to end-stage renal disease.</li>\n<li>The study met its primary endpoint of a statistically valid reduction (more than two-fold) in proteinuria (protein in urine) compared to irbesartan [Sanofi's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SNY\" title=\"Sanofi\">SNY</a>) <a href=\"https://www.drugs.com/avapro.html\" target=\"_blank\">Avapro</a>] after an eight-week treatment period. Specifically, patients treated with 200, 400 and 800 mg/day of sparsentan (n=64) showed a mean reduction of proteinuria from baseline of 44.8% after eight weeks of treatment compared to 18% for those (n=32) receiving 300 mg/day of irbesartan (p=0.006). The 400 mg and 800 mg sparsentan cohorts also showed superiority to 300 mg of irbesartan, 47.4% vs. 19.0% (p=0.011).</li>\n<li>The individual sparsentan cohorts, however, failed to show statistically valid superiority to irbesartan although clear signals of relative improvement were observed.</li>\n<li>The company plans to present the data at an upcoming medical conference or submit it for publication.</li>\n<li>Management will host a conference call this morning at 8:30 am ET to discuss the data.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207324\" data-linked=\"Retrophin&#39;s sparsentan successful in mid-stage study in rare kidney disorder; shares ahead 29% premarket\" data-tweet=\"$RTRX $RTRX $SNY - Retrophin&#39;s sparsentan successful in mid-stage study in rare kidney disorder; shares ahead 29% premarket https://seekingalpha.com/news/3207324-retrophins-sparsentan-successful-in-mid-stage-study-in-rare-kidney-disorder-shares-ahead-29?source=tweet\" data-url=\"https://seekingalpha.com/news/3207324-retrophins-sparsentan-successful-in-mid-stage-study-in-rare-kidney-disorder-shares-ahead-29\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207307\" data-ts=\"1473249663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GIS\" target=\"_blank\">GIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207307-general-mills-updates-on-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">General Mills updates on guidance</a></h4><ul> <li>General Mills (NYSE:<a href=\"https://seekingalpha.com/symbol/GIS\" title=\"General Mills, Inc.\">GIS</a>) says it expects to meet key FY17 targets, including organic sales growth of 0% to -2% and total segment operating profit growth between +6% and +8% in constant currency.</li> <li>The company will have some catching up to do because it anticipates that organic sales growth in FQ1 will be below its full-year guidance range.</li> <li>Execs are due to present later today at the Barclays Global Consumer Staples Conference.</li> <li>GIS <font color=\"red\">-1.27%</font> premarket to $70.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207307\" data-linked=\"General Mills updates on guidance\" data-tweet=\"$GIS - General Mills updates on guidance https://seekingalpha.com/news/3207307-general-mills-updates-on-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3207307-general-mills-updates-on-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207302\" data-ts=\"1473249028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMNP\" target=\"_blank\">IMNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207302-immune-pharma-sells-4m-shares-of-stock-to-existing-stockholder-0_50-shares-up-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immune Pharma sells 4M shares of stock to existing stockholder at $0.50; shares up 13% premarket</a></h4><ul><li>Nano cap Immune Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a>) inks a <a href=\"https://www.sec.gov/Archives/edgar/data/1208261/000114420416122981/v448347_8k.htm\" target=\"_blank\">stock purchase agreement</a> with an existing shareholder for the sale of 4M shares of common stock at $0.50 a share. Closing date is today.</li><li>Yesterday's close was $0.323.</li></ul><div class=\"tiny-share-widget\" data-id=\"3207302\" data-linked=\"Immune Pharma sells 4M shares of stock to existing stockholder at $0.50; shares up 13% premarket\" data-tweet=\"$IMNP $IMNPQ - Immune Pharma sells 4M shares of stock to existing stockholder at $0.50; shares up 13% premarket https://seekingalpha.com/news/3207302-immune-pharma-sells-4m-shares-of-stock-to-existing-stockholder-0_50-shares-up-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3207302-immune-pharma-sells-4m-shares-of-stock-to-existing-stockholder-0_50-shares-up-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207293\" data-ts=\"1473247704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207293-western-digital-up-5-after-lifting-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Digital up 5% after lifting outlook</a></h4><ul>\n<li>The company expects FQ1 revenue of $4.45B-$4.55B vs. an earlier forecast of $4.4B-$4.5B. Non-GAAP gross margin of 33% is up 100 basis points from previous.</li>\n<li>FQ1 EPS is now seen at $1.00-$1.05 vs. previous $0.85-$0.90.</li>\n<li>Full results are due in late October.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/WDC\" title=\"Western Digital Corporation\">WDC</a> <font color=\"green\">+5.5%</font>, <a href=\"https://seekingalpha.com/symbol/STX\" title=\"Seagate Technology\">STX</a> <font color=\"green\">+1.6%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3207293\" data-linked=\"Western Digital up 5% after lifting outlook\" data-tweet=\"$WDC $WDC $STX - Western Digital up 5% after lifting outlook https://seekingalpha.com/news/3207293-western-digital-up-5-after-lifting-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3207293-western-digital-up-5-after-lifting-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3207292\" data-ts=\"1473247615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFM\" target=\"_blank\">SFM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3207292-sprouts-farmers-market-slumps-after-updating-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprouts Farmers Market slumps after updating guidance</a></h4><ul> <li>Sprouts Farmers Market (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SFM\" title=\"Sprouts Farmers Market\">SFM</a>) updates guidance in advance of a presentation at the Goldman Sachs 23rd Annual Global Retailing Conference.</li> <li>The company expects full-year 2016 comparable store sales growth to be in the range of 1.5% to 2.5% and EPS to fall in a range of $0.83 to $0.86 vs. $0.94 consensus.</li> <li>\"The prolonged deflationary environment, competitive landscape and industry dynamics have prompted heavy promotions across the industry, adversely impacting retail deflation and traffic generation,\" says Sprouts.</li> <li>Shares of Sprouts are <font color=\"red\">down 6.8%</font> premarket to $21.26.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3207292\" data-linked=\"Sprouts Farmers Market slumps after updating guidance\" data-tweet=\"$SFM - Sprouts Farmers Market slumps after updating guidance https://seekingalpha.com/news/3207292-sprouts-farmers-market-slumps-after-updating-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3207292-sprouts-farmers-market-slumps-after-updating-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":53,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}